MAM
ZYME icon

Martingale Asset Management’s Zymeworks ZYME Stock Holding History

Martingale Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
73,282
+40,518
+124% +$1.03M 0.05% 401
2026
Q1 		$820K Buy
+32,764
New +$775K 0.02% 543

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Martingale Asset Management's ZYME Position: Q2 2026 in Review

Martingale Asset Management increased its Zymeworks (ZYME) stake by 124% in Q2 2026, buying an estimated $1.03M and bringing the position to 73,282 shares worth $1.92M. The position accounts for 0.05% of the portfolio, ranked #401.

Martingale Asset Management first reported a position in ZYME in Q1 2026 and has held it in 2 quarters since. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Martingale Asset Management held 73,282 shares of Zymeworks worth $1.92M as of Q2 2026.
  • Martingale Asset Management bought 40,518 Zymeworks shares in Q2 2026, an estimated $1.03M.
  • Zymeworks made up 0.05% of Martingale Asset Management's portfolio in Q2 2026, its #401 holding.
  • Martingale Asset Management first reported a position in Zymeworks in Q1 2026 and has held it in 2 quarters since.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Martingale Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.